Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 07 04:00PM ET
71.54
Dollar change
+0.92
Percentage change
1.30
%
IndexS&P 500 P/E21.30 EPS (ttm)3.36 Insider Own1.38% Shs Outstand131.79M Perf Week7.21%
Market Cap9.30B Forward P/E13.67 EPS next Y5.23 Insider Trans-0.92% Shs Float128.14M Perf Month13.63%
Income445.00M PEG2.51 EPS next Q0.72 Inst Own94.88% Short Float / Ratio2.70% / 3.17 Perf Quarter-3.17%
Sales12.69B P/S0.73 EPS this Y-15.21% Inst Trans0.53% Short Interest3.46M Perf Half Y-4.54%
Book/sh28.10 P/B2.55 EPS next Y14.70% ROA4.85% Target Price73.74 Perf Year-11.28%
Cash/sh1.28 P/C56.00 EPS next 5Y8.50% ROE12.26% 52W Range60.01 - 89.72 Perf YTD-10.43%
Dividend- P/FCF14.32 EPS past 5Y8.75% ROI7.70% 52W High-20.26% Beta0.81
Dividend %- Quick Ratio1.09 Sales past 5Y1.50% Gross Margin29.45% 52W Low19.21% ATR1.68
Employees22000 Current Ratio1.97 Sales Q/Q3.10% Oper. Margin6.52% RSI (14)63.63 Volatility2.94% 2.52%
OptionableYes Debt/Eq0.63 EPS Q/Q-4.74% Profit Margin3.51% Rel Volume1.37 Prev Close70.62
ShortableYes LT Debt/Eq0.58 EarningsNov 13 BMO Payout0.00% Avg Volume1.09M Price71.54
Recom2.79 SMA205.52% SMA503.83% SMA200-5.76% Volume1,494,425 Change1.30%
Date Action Analyst Rating Change Price Target Change
Nov-10-23Upgrade Stifel Hold → Buy $70
Aug-08-22Upgrade UBS Sell → Neutral $80
Jul-21-22Downgrade Goldman Buy → Neutral $93 → $85
Jun-14-22Downgrade Robert W. Baird Outperform → Neutral $103 → $88
May-13-22Resumed Credit Suisse Outperform $100
Jan-31-22Initiated Morgan Stanley Underweight $67
Jan-07-22Upgrade Credit Suisse Neutral → Outperform $78 → $90
Oct-01-21Resumed Credit Suisse Neutral $78
Feb-08-21Resumed Piper Sandler Overweight $83
Jan-04-21Upgrade Robert W. Baird Neutral → Outperform $70 → $79
Dec-05-23 07:37AM
Dec-04-23 02:00AM
Dec-03-23 04:00PM
Nov-30-23 06:29AM
Nov-28-23 06:30AM
05:10PM Loading…
Nov-16-23 05:10PM
Nov-14-23 01:19PM
07:20AM
05:50AM
Nov-13-23 05:25PM
04:50PM
03:56PM
12:37PM
10:59AM
09:30AM
07:15AM Loading…
07:15AM
07:00AM
06:58AM
06:07AM
06:00AM
06:00AM
Nov-10-23 11:50AM
Nov-08-23 04:00PM
07:00AM
Nov-07-23 07:00AM
Nov-02-23 04:10PM
10:00AM
Oct-31-23 10:01AM
Oct-30-23 08:41AM
Oct-25-23 05:20AM
09:05AM Loading…
Oct-24-23 09:05AM
Oct-18-23 09:40AM
12:30AM
Oct-17-23 04:15PM
09:40AM
Oct-16-23 04:59PM
12:13PM
12:11PM
11:36AM
09:45AM
Oct-15-23 11:30PM
Oct-10-23 11:40AM
09:50AM
Oct-05-23 08:30AM
Oct-04-23 08:41AM
06:31AM
Sep-27-23 12:34PM
09:45AM
Sep-26-23 11:10AM
Sep-20-23 09:40AM
Sep-14-23 06:30AM
Sep-08-23 09:45AM
Sep-06-23 11:30AM
06:30AM
Sep-05-23 06:30AM
Aug-29-23 06:50PM
11:02AM
09:40AM
Aug-17-23 06:31AM
Aug-10-23 02:00PM
09:06AM
Aug-09-23 06:31AM
Aug-08-23 01:46AM
Aug-07-23 12:36PM
12:34PM
10:25AM
09:30AM
07:40AM
07:40AM
06:38AM
06:30AM
Aug-03-23 08:35AM
06:30AM
Aug-02-23 06:30AM
Jul-31-23 06:30AM
Jul-28-23 08:09AM
Jul-26-23 06:30AM
Jul-17-23 06:30AM
Jul-13-23 06:30AM
Jul-10-23 06:30AM
Jul-09-23 04:04AM
Jul-06-23 06:15PM
Jun-30-23 06:00PM
Jun-29-23 06:15PM
Jun-26-23 08:41AM
Jun-23-23 06:00PM
Jun-21-23 08:00PM
06:30AM
Jun-20-23 06:15PM
06:30AM
Jun-15-23 08:18AM
Jun-13-23 06:00PM
Jun-08-23 11:30AM
Jun-07-23 06:00PM
Jun-06-23 06:04AM
May-24-23 06:43AM
May-17-23 01:41PM
06:30AM
May-16-23 09:03AM
May-10-23 01:19AM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brous David B JrCEO, Strategic Business GroupJun 12Sale74.8611,157835,19168,690Jun 13 04:35 PM
Siegel WalterSr. VP & Chief Legal OfficerJun 05Sale74.075,497407,16335,737Jun 07 04:07 PM
BRESLAWSKI JAMES PVice Chairman, PresidentJun 02Sale74.2924,2341,800,453201,555Jun 06 04:04 PM
Ettinger Michael SEVP & Chief Operating OfficerMay 24Sale75.1214,8811,117,86175,710May 25 04:48 PM
MLOTEK MARK EEVP, Chief Strategic OfficerMay 19Sale76.6824,7471,897,60069,138May 23 04:18 PM
KUEHN KURT PDirectorMar 16Sale77.461,909147,87115,675Mar 17 04:17 PM
Siegel WalterSr. VP & Chief Legal OfficerMar 06Sale78.625,000393,10041,234Mar 07 04:48 PM
LASKAWY PHILIP ADirectorMar 03Sale78.746,405504,33026,239Mar 07 04:12 PM
SHEARES BRADLEY TDirectorFeb 22Sale82.0711,243922,71338,861Feb 23 04:20 PM
Connett Bradford CCEO, NA Distribution GroupDec 21Sale80.716,840552,05655,412Dec 22 04:12 PM
McGlynn LoreleiSVP, Chief Human Res. OfficerDec 20Sale80.7015,3411,238,04973,753Dec 21 04:14 PM
BERGMAN STANLEY MChairman, CEODec 12Sale81.1654,2164,400,189488,126Dec 13 06:13 PM